Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 4/2010

01-08-2010

Musculoskeletal Pain Associated With Corticosteroid Therapy in Cancer

Author: Deborah A. Frieze

Published in: Current Pain and Headache Reports | Issue 4/2010

Login to get access

Abstract

Corticosteroids have multiple uses in the care of the cancer patient. Although they confer benefit to the patient, high doses and extended duration of use may lead to significant adverse effects. Adverse effects such as osteoporosis-induced fractures, osteonecrosis, myopathy and myalgias can cause significant pain and have a negative impact on the patient’s quality of life. In this paper, I will review the mechanisms involved in the toxicity, risk factors, prevalence, prevention, and treatment strategies.
Literature
1.
Fisher RI, Gaynor ER, Dahlberg S, et al.: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 1993, 328:1002–1006.CrossRefPubMed
2.
Cavo M, Zamagni E, Tosi P, et al.: Superiority of thalidomide and dexamethasone over vincristine-doxorubicin-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. Blood 2005, 106:35–39.CrossRefPubMed
3.
Eastell R, Reid DM, Compston J, et al.: A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998, 244:271–292.CrossRefPubMed
4.
Talamo G, Angtuaco E, Walker RC, et al.: Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy. J Clin Oncol 2005, 23:5217–5223.CrossRefPubMed
5.
Manolagas SC, Weinstein RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999, 14:1061–1066.CrossRefPubMed
6.
• Fardet L, Kassar A, Cabane J, Flahault A: Corticocosteroid-induced adverse events in adults. Drug Saf 2007, 30:861–881. This is a comprehensive review of corticosteroid-induced adverse effects.CrossRefPubMed
7.
Hollister JR: The untoward effects of steroid treatment on the musculoskeletal system and what to do about them. J Asthma 1992, 29:363–368.CrossRefPubMed
8.
Homik J, Suarez-Almazor ME, Shea B, et al.: Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000, (2):CD000952.PubMed
9.
Rosen LS, Gordon D, Tchekmedyian S, et al.: Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial—the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003, 21:3150–3157.CrossRefPubMed
10.
Bower M, Stein RC, Hedley A, et al.: The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy. Cancer Chemother Pharmacol 1991, 28:311–312.PubMed
11.
O’Brien TJ, Mack GR: Multifocal osteonecrosis after short-term high-dose corticosteroid therapy: a case report. Clin Orthop Relat Res 1992, 279:176–179.
12.
Yildiz N, Ardic F, Deniz S: Very early onset steroid-induced avascular necrosis of the hip and knee in a patient with idiopathic thrombocytopenic purpura. Intern Med 2008, 47:1989–1992.CrossRefPubMed
13.
Weldon D: The effects of corticosteroids on bone: osteonecrosis (avascular necrosis of the bone). Ann Allergy Asthma Immunol 2009, 103:91–97.CrossRefPubMed
14.
Ajmal M, Matas AJ, Kuskowski M, Cheng EY: Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am 2009, 40:235–239.CrossRefPubMed
15.
Arico M, Pinta Boccalatte MR, et al.: Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003, 88:747–753.PubMed
16.
Mattano LA Jr, Sather HN, Trigg ME, Nachman JB: Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Study Group. J Clin Oncol 2000, 18:3262–3272.PubMed
17.
Strauss A, Su JT, Dalton VM, et al.: Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001, 19:3066–3072.PubMed
18.
• Campbell S, Sun CL, Kurian S, et al.: Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 2009, 115:4127–4135. This is a valuable study identifying potential predictors of avascular necrosis.CrossRefPubMed
19.
Shim K, MacKenzie MJ, Winquist E: Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review. Drug Saf 2008, 31:359–371.CrossRefPubMed
20.
Tombolini V, Capua A, Pompili E: Avascular necrosis of the femoral head after treatment of Hodgkin’s disease. Acta Oncol 1992, 31:64–65.CrossRefPubMed
21.
van den Berkmortel F, de Wit R, de Rooy J, DeMulder P: Osteonecrosis in patients with testicular tumours treated with chemotherapy. Neth J Med 2004, 62:23–27. [Published erratum appears in Neth J Med 2004, 62:103.]
22.
Cook AM, Dzik-Jurasz AS, Padhani AR, et al.: The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours. Br J Cancer 2001, 85:1624–1626.CrossRefPubMed
23.
Zadegan F, Raould A, Bizot P, et al.: Osteonecrosis after allogeneic bone marrow transplantation. Clin Orthop Relat Res 2008, 466:287–293.CrossRefPubMed
24.
Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations. Johns Hopkins Med J 1932, 50:137–195.
25.
26.
Batchelor RR, Taylor LP, Thaler HT, et al.: Steroid myopathy in cancer patients. Neurology 1997, 48:1234–1238.PubMed
27.
Walsh LJ, Wong CA, Oborne J, et al.: Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001, 56:279–284.CrossRefPubMed
28.
Askari A, Vignos PJ Jr, Moskowitz RW: Steroid myopathy in connective tissue disease. Am J Med 1976, 61:485–492.CrossRefPubMed
29.
•• Schakman O, Gilson H, Thissen JP: Mechanisms of glucocorticoid-induced myopathy. J Endocrinology 2008, 197:1–10. This is an excellent review with a thorough discussion of glucocorticoid-induced myopathy.CrossRef
30.
31.
32.
Blakeley JO, Peng T, Ye X, Grossman SA : Dose and duration of dexamethasone in patients with high grade gliomas (HGG): relationship to steroid myopathy (SM). American Society of Clinical Oncology Annual Meeting Proceedings Part I. J Clin Oncol 2006, 24(18S):Abstract 18517.
Metadata
Title
Musculoskeletal Pain Associated With Corticosteroid Therapy in Cancer
Author
Deborah A. Frieze
Publication date
01-08-2010
Publisher
Current Science Inc.
Published in
Current Pain and Headache Reports / Issue 4/2010
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-010-0120-z

Other articles of this Issue 4/2010

Current Pain and Headache Reports 4/2010 Go to the issue

ReviewPaper

Fasting Headache

ReviewPaper

Posttraumatic Headache: A Review

ReviewPaper

Hypnic Headache

ReviewPaper

Headaches Due to External Compression

ReviewPaper

Migraine and Epilepsy: A Focus on Overlapping Clinical, Pathophysiological, Molecular, and Therapeutic Aspects

Clinical Trial Report

Phenothiazines in Migraine Treatment